Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101704
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101704
Table 3 Biochemical parameters at the baseline and at weeks 12 and 24 in the intervention group with metabolic dysfunction-associated steatotic liver disease
Biochemical parameters
Baseline
12 weeks
24 weeks
P value
Leukocytes in thousands/μL17.1 (5.3-13.7)5.7 (4.5-10)7.0 (4.7-12)0.876
Hb in g/dL213.4 + 1.313.1 + 1.313.3 + 1.20.101
Platelets in miles/μL2278 + 52259 + 59256 + 570.014
TB in mg/dL20.54 + 0.240.60 + 0.180.72 + 0.200.002
AST in U/L127 (11-49)25 (20-63)24 (15-45)0.201
ALT in U/L132 (4-102)30 (17-81)25 (17-69)0.267
ALP in IU/L299 + 4992 + 2481 + 160.205
GGT in U/L151 (18-370)25 (10-130)28 (12-142)0.033
TP in g/dL17.4 (6.4-8.3)7.4 (6.6-8.1)7.4 (7.0-8.3)0.125
Albumin in g/dL24.3 + 0.564.3 + 0.284.4 + 0.30.443
Cholesterol in mg/dL2202 + 45191 + 52184 + 490.073
    HDL in mg/dL144 (23-66)40 (31-61)46 (29-168)0.850
    LDL in mg/dL2123 + 41113 + 39110 + 370.056
    VLDL in mg/dL231 + 1141 + 4332 + 150.663
Triglycerides in mg/dL2165 + 11163 + 5532 + 760.987
Glucose in mg/dL1110 (69-316)101 (83-200)115 (91-242)0.616
Creatinine in mg/dL20.77 + 0.160.67 + 0.140.66 + 0.250.223
CRP in mg/L14.60 (0.50-1.03)3.90 (1.80-6.00)0.51 (0.03-1.40)0.035
Insulin in mg/L216.0 + 9.820.0 + 11.016.0 + 5.00.580
HOMA24.8 + 3.05.7 + 3.35.3 + 2.80.230